{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T21:40:52Z","timestamp":1760218852768,"version":"build-2065373602"},"reference-count":28,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2014,7,31]],"date-time":"2014-07-31T00:00:00Z","timestamp":1406764800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJERPH"],"abstract":"<jats:p>Before effective vaccines become available, antiviral drugs are considered as the major control strategies for a pandemic influenza. However, perhaps such control strategies can be severely hindered by the low-efficacy of antiviral drugs. For this reason, using antiviral drugs and an isolation strategy is included in our study. A compartmental model that allows for imported exposed individuals and asymptomatic cases is used to evaluate the effectiveness of control strategies via antiviral prophylaxis and isolation. Simulations show that isolation strategy plays a prominent role in containing transmission when antiviral drugs are not effective enough. Moreover, relatively few infected individuals need to be isolated per day. Because the accurate calculations of the needed numbers of antiviral drugs and the isolated infected are not easily available, we give two simple expressions approximating these numbers. We also derive an estimation for the total cost of these intervention strategies. These estimations obtained by a simple method provide a useful reference for the management department about the epidemic preparedness plans.<\/jats:p>","DOI":"10.3390\/ijerph110807690","type":"journal-article","created":{"date-parts":[[2014,8,4]],"date-time":"2014-08-04T08:06:18Z","timestamp":1407139578000},"page":"7690-7712","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Antiviral Prophylaxis and Isolation for the Control of Pandemic Influenza"],"prefix":"10.3390","volume":"11","author":[{"given":"Qingxia","family":"Zhang","sequence":"first","affiliation":[{"name":"School of Mathematical Sciences, University of Electronic Science and Technology of China, No. 2006, Xiyuan Avenue, West Hi-Tech Zone, Chengdu 611731, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dingcheng","family":"Wang","sequence":"additional","affiliation":[{"name":"School of Mathematical Sciences, University of Electronic Science and Technology of China, No. 2006, Xiyuan Avenue, West Hi-Tech Zone, Chengdu 611731, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2014,7,31]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/nature02746","article-title":"Genesis of a highly pathogenic and potentially pandemic H5N1 influenza virus in Eastern Asia","volume":"430","author":"Li","year":"2004","journal-title":"Nature"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1056\/NEJMra052211","article-title":"Avian influenza a (H5N1) infection in humans","volume":"353","author":"Beigel","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1098\/rsif.2007.1152","article-title":"Antiviral treatment for the control of pandemic influenza: Some logistical constraints","volume":"5","author":"Arinaminpathy","year":"2008","journal-title":"J. R. Soc. Interface"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.mbs.2007.02.003","article-title":"Prophylaxis or treatment? Optimal use of an antiviral stockpile during an influenza pandemic","volume":"209","author":"McCaw","year":"2007","journal-title":"Math. Biosci."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1086\/375056","article-title":"Pandemic influenza and the global vaccine supply","volume":"36","author":"Fedson","year":"2003","journal-title":"Clin. Infect. Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1126\/science.1090350","article-title":"Are we ready for pandemic influenza?","volume":"302","author":"Webby","year":"2003","journal-title":"Science"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.mbs.2007.02.008","article-title":"The role of health care workers and antiviral drugs in the control of pandemic influenza","volume":"209","author":"Barnes","year":"2007","journal-title":"Math. Biosci."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1126\/science.1115717","article-title":"Containing pandemic influenza at the source","volume":"309","author":"Longini","year":"2005","journal-title":"Science"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Black, A.J., House, T., Keeling, M.J., and Ross, J.V. (2013). Epidemiological consequences of household-based antiviral prophylaxis for pandemic influenza. J. R. Soc. Interface, 10.","DOI":"10.1098\/rsif.2012.1019"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Cheng, M.H. (2005). Flu, what flu. Lancet Infect. Dis., 5.","DOI":"10.1016\/S1473-3099(05)70290-5"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1503\/cmaj.050332","article-title":"Feds to stockpile antivirals as pandemic \u201cspeed bump\u201d","volume":"172","author":"Lett","year":"2005","journal-title":"Can. Med. Assoc. J."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"6793","DOI":"10.1016\/j.vaccine.2006.06.068","article-title":"Influenza as an issue on the agenda of policymakers and government representatives. What can we do? What do we need?","volume":"24","author":"Esveld","year":"2006","journal-title":"Vaccine"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.5694\/j.1326-5377.2006.tb00709.x","article-title":"Antivirals in the management of an influenza pandemic","volume":"185","author":"Harrod","year":"2006","journal-title":"Med. J. Aust."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Becker, N.G., and Wang, D. (2011). Can Antiviral Drugs Contain Pandemic Influenza Transmission?. PLoS One, 6.","DOI":"10.1371\/journal.pone.0017764"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jtbi.2010.04.003","article-title":"Optimal control for pandemic influenza: The role of limited antiviral treatment and isolation","volume":"265","author":"Lee","year":"2010","journal-title":"J. Theor. Biol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.mcm.2007.04.003","article-title":"Optimal and sub-optimal quarantine and isolation control in SARS epidemics","volume":"47","author":"Yan","year":"2008","journal-title":"Math. Comput. Model."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Merler, S., Ajelli, M., and Rizzo, C. (2009). Age-prioritized use of antivirals during an influenza pandemic. BMC Infect. Dis., 9.","DOI":"10.1186\/1471-2334-9-117"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1098\/rsif.2006.0112","article-title":"Simple models for containment of a pandemic","volume":"3","author":"Arino","year":"2006","journal-title":"J. R. Soc. Interface"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/nature04017","article-title":"Strategies for containing an emerging influenza pandemic in Southeast Asia","volume":"437","author":"Ferguson","year":"2005","journal-title":"Nature"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1098\/rspb.2004.2800","article-title":"Modelling strategies for controlling SARS outbreaks","volume":"271","author":"Gumel","year":"2004","journal-title":"Proc. R. Soc. Lond. B"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/nature04795","article-title":"Strategies for mitigating an influenza pandemic","volume":"442","author":"Ferguson","year":"2006","journal-title":"Nature"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.mbs.2011.10.009","article-title":"Reproduction numbers for epidemic models with households and other social structures. I. Definition and calculation of R0","volume":"235","author":"Pellis","year":"2012","journal-title":"Math. Biosci."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jtbi.2011.08.011","article-title":"Antiviral treatment for pandemic influenza: Assessing potential repercussions using a seasonally forced SIR model","volume":"289","author":"Towers","year":"2011","journal-title":"J. Theor. Biol."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Becker, N.G., Wang, D., and Clements, M. (2010). Type and quantity of data needed for an early estimate of transmissibility when an infectious disease emerges. Eurosurveillance, 15.","DOI":"10.2807\/ese.15.26.19603-en"},{"key":"ref_25","first-page":"29","article-title":"Reproduction numbers and sub-threshold endemic equilibria for compartmental models of disease transmission","volume":"180","author":"Watmough","year":"2002","journal-title":"J. Math. Biol."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Ludkovski, M., and Niemi, J. (2010). Optimal dynamic policies for influenza management. Stat. Commun. Infect. Dis., 2.","DOI":"10.2202\/1948-4690.1020"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Yarmand, H. (2010). Cost-Effectiveness Analysis of Vaccination and Self-Isolation in Case of H1N1. [Master\u2019s Thesis, North Carolina State University].","DOI":"10.1109\/WSC.2010.5678918"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Hayward, A.C., Fragaszy, E.B., Bermingham, A., Wang, L., Copas, A., Edmunds, W.J., Ferguson, N., Goonetilleke, N., Harvey, G., and Kovar, J. (2014). Comparative community burden and severity of seasonal and pandemic influenza: Results of the Flu Watch cohort study. Lancet Respir. Med., 2014.","DOI":"10.1016\/S2213-2600(14)70034-7"}],"container-title":["International Journal of Environmental Research and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1660-4601\/11\/8\/7690\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T21:14:14Z","timestamp":1760217254000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1660-4601\/11\/8\/7690"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,31]]},"references-count":28,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2014,8]]}},"alternative-id":["ijerph110807690"],"URL":"https:\/\/doi.org\/10.3390\/ijerph110807690","relation":{},"ISSN":["1660-4601"],"issn-type":[{"type":"electronic","value":"1660-4601"}],"subject":[],"published":{"date-parts":[[2014,7,31]]}}}